GE HealthCare Technologies Sees Unusually High Options Volume (NASDAQ:GEHC)

GE HealthCare Technologies Inc. (NASDAQ:GEHC) was the target of some unusual options trading activity on Wednesday. Investors acquired 8,956 call options on the stock. This is an increase of approximately 45% compared to the average volume of 6,169 call options.

Analysts Set New Price Targets

GEHC has been the topic of a number of recent research reports. Piper Sandler reduced their price target on shares of GE HealthCare Technologies from $88.00 to $74.00 in a research report on Thursday, April 30th. Argus reduced their price target on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Tuesday, May 19th. Evercore set a $80.00 target price on shares of GE HealthCare Technologies in a report on Thursday, April 30th. Citigroup reiterated a “neutral” rating on shares of GE HealthCare Technologies in a research note on Wednesday, July 8th. Finally, BTIG Research reiterated a “buy” rating and issued a $75.00 target price on shares of GE HealthCare Technologies in a research note on Monday, July 13th. Ten investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $76.41.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Peter J. Arduini acquired 4,169 shares of the company’s stock in a transaction on Thursday, April 30th. The shares were acquired at an average cost of $59.92 per share, with a total value of $249,806.48. Following the completion of the acquisition, the chief executive officer directly owned 259,424 shares in the company, valued at $15,544,686.08. This trade represents a 1.63% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Frank R. Jimenez bought 1,750 shares of the business’s stock in a transaction on Thursday, April 30th. The stock was bought at an average price of $60.45 per share, with a total value of $105,787.50. Following the purchase, the insider owned 93,932 shares in the company, valued at $5,678,189.40. This trade represents a 1.90% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have bought 21,847 shares of company stock valued at $1,361,355 over the last 90 days. Corporate insiders own 0.36% of the company’s stock.

Institutional Investors Weigh In On GE HealthCare Technologies

A number of institutional investors and hedge funds have recently modified their holdings of the company. Auto Owners Insurance Co boosted its position in GE HealthCare Technologies by 9,525.4% in the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after purchasing an additional 33,629,559 shares in the last quarter. Norges Bank acquired a new position in GE HealthCare Technologies in the 4th quarter valued at $596,024,000. Barrow Hanley Mewhinney & Strauss LLC purchased a new stake in GE HealthCare Technologies during the 4th quarter valued at about $533,655,000. Cynosure Group LLC increased its stake in shares of GE HealthCare Technologies by 21,045.4% in the 4th quarter. Cynosure Group LLC now owns 4,365,462 shares of the company’s stock worth $358,055,000 after acquiring an additional 4,344,817 shares during the last quarter. Finally, Boston Partners acquired a new position in GE HealthCare Technologies in the 3rd quarter valued at about $287,627,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Trending Headlines about GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: GEHC beat earnings and revenue estimates. Adjusted earnings were $1.13 per share, above the $1.04 consensus and up from $1.06 a year earlier. Revenue rose approximately 5.7% to $5.29 billion, slightly exceeding the $5.26 billion estimate. GE HealthCare Technologies Beats Q2 Earnings and Revenue Estimates
• Positive Sentiment: Orders and backlog reached records. Orders increased 11.1%, with growth reported across every segment, while backlog climbed to $23.9 billion. The results suggest solid demand and improved visibility for future revenue. GEHC Q2 Earnings and Revenues Beat Estimates
• Positive Sentiment: Imaging demand supported profitability. Strong demand for diagnostic and imaging devices helped drive the quarterly performance. Refunds related to U.S. tariffs also benefited results. GE HealthCare Beats Quarterly Profit Estimates
• Positive Sentiment: Options activity reflected bullish positioning. Traders purchased 8,956 call options, about 45% above average call volume, indicating increased speculative interest following the earnings report.
• Neutral Sentiment: Management said Patient Care Solutions remains a focus as it works to restore growth and profitability, and the company is reviewing strategies for that business. This creates a continuing execution risk despite the strong consolidated results. GE HealthCare Reports Second Quarter 2026 Financial Results

GE HealthCare Technologies Price Performance

Shares of GE HealthCare Technologies stock traded up $7.39 during trading on Wednesday, reaching $71.50. 8,663,029 shares of the stock traded hands, compared to its average volume of 4,537,603. The business has a fifty day simple moving average of $63.68 and a two-hundred day simple moving average of $70.80. GE HealthCare Technologies has a 52-week low of $58.75 and a 52-week high of $89.77. The company has a market capitalization of $32.52 billion, a price-to-earnings ratio of 17.12, a P/E/G ratio of 1.66 and a beta of 0.72. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $1.13 EPS for the quarter, topping the consensus estimate of $1.04 by $0.09. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company had revenue of $5.29 billion during the quarter, compared to analyst estimates of $5.26 billion. During the same period in the previous year, the firm earned $1.06 earnings per share. GE HealthCare Technologies’s quarterly revenue was up 5.8% compared to the same quarter last year. Sell-side analysts expect that GE HealthCare Technologies will post 4.89 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, July 24th. GE HealthCare Technologies’s payout ratio is 3.35%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.